CNS Pharmaceuticals Inc (CNSP)
0.216
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
0.212
0.00 (0.00%)
Pre-Market: 08:58
CNS Pharmaceuticals Shareholders Equity (Quarterly): -4.430M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.430M |
| December 31, 2023 | -4.432M |
| September 30, 2023 | -1.741M |
| June 30, 2023 | 2.454M |
| March 31, 2023 | 3.492M |
| December 31, 2022 | 8.133M |
| September 30, 2022 | 8.394M |
| June 30, 2022 | 11.52M |
| March 31, 2022 | 14.80M |
| December 31, 2021 | 6.163M |
| September 30, 2021 | 9.100M |
| Date | Value |
|---|---|
| June 30, 2021 | 12.41M |
| March 31, 2021 | 11.24M |
| December 31, 2020 | 13.95M |
| September 30, 2020 | 2.474M |
| June 30, 2020 | 3.725M |
| March 31, 2020 | 5.875M |
| December 31, 2019 | 7.601M |
| September 30, 2019 | 0.0002M |
| June 30, 2019 | 0.3777M |
| December 31, 2018 | -0.5493M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.432M
Minimum
Dec 2023
14.80M
Maximum
Mar 2022
5.556M
Average
6.019M
Median
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.661M |
| Total Liabilities (Quarterly) | 6.091M |